Irinotecan hydrochloride is a pharmaceutical raw material used in the manufacture of anticancer medications. It is a salt form of irinotecan, a compound that acts through inhibition of topoisomerase I.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 100286-90-6
Irinotecan hydrochloride trihydrate
pharmaceutical raw material
Irinotecan
pharmaceutical raw material
Milrinone lactate
pharmaceutical raw material
Ferrous succinate
pharmaceutical raw material
Sodium picosulfate
pharmaceutical raw material
Cobicistat
pharmaceutical raw material
[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;hydrochloride
GURKHSYORGJETM-WAQYZQTGSA-N
CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.Cl